{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:38:09Z","timestamp":1788838689710,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Louisiana State University in Shreveport"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40256-025-00720-5","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:12:10Z","timestamp":1739898730000},"page":"469-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety and Efficacy of DOAC Versus VKA in Adult Congenital Heart Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-3047","authenticated-orcid":false,"given":"Aamina","family":"Shakir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinthe","family":"Khater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-2046","authenticated-orcid":false,"given":"Erin","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-7620","authenticated-orcid":false,"given":"George","family":"Mina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-0846","authenticated-orcid":false,"given":"Khagendra","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-0826","authenticated-orcid":false,"given":"Kalgi","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"14","key":"720_CR1","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1161\/CIR.0000000000000603","volume":"139","author":"KK Stout","year":"2019","unstructured":"Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA\/ACC Guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):e698\u2013800. https:\/\/doi.org\/10.1161\/CIR.0000000000000603. (Erratum in: Circulation. 2019 Apr 2;139(14):e833-e834. 10.1161\/CIR.0000000000000683. PMID: 30586767).","journal-title":"Circulation"},{"issue":"6","key":"720_CR2","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/jcm9061794","volume":"9","author":"N Stalikas","year":"2020","unstructured":"Stalikas N, Doundoulakis I, Karagiannidis E, Bouras E, Kartas A, Frogoudaki A, Karvounis H, Dimopoulos K, Giannakoulas G. Non-vitamin K oral anticoagulants in adults with congenital heart disease: a systematic review. J Clin Med. 2020;9(6):1794. https:\/\/doi.org\/10.3390\/jcm9061794. (PMID:32526897;PMCID:PMC7356004).","journal-title":"J Clin Med"},{"issue":"6","key":"720_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","volume":"42","author":"H Baumgartner","year":"2021","unstructured":"Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563\u2013645. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa554. (PMID: 32860028).","journal-title":"Eur Heart J"},{"issue":"13","key":"720_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden AB. direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13): e017559. https:\/\/doi.org\/10.1161\/JAHA.120.017559. (Epub 2020 Jun 15. PMID: 32538234; PMCID: PMC7670541).","journal-title":"J Am Heart Assoc"},{"key":"720_CR5","doi-asserted-by":"publisher","unstructured":"Higgins JP, Green S, editors: Cochrane Handbook for Systematic Reviews of Interventions [Internet]. Chichester, UK: John Wiley & Sons, Ltd, 2008 [cited 2021 Jan 26]. Available from: http:\/\/doi.wiley.com\/https:\/\/doi.org\/10.1002\/9780470712184","DOI":"10.1002\/9780470712184"},{"key":"720_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151:264.","journal-title":"Ann Intern Med"},{"key":"720_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4.)","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan \u2014 a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.).","journal-title":"Syst Rev"},{"key":"720_CR8","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928\u2013d5928.","journal-title":"BMJ"},{"key":"720_CR9","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. 2009. Available from http:\/\/www.ohrica\/programs\/clinical_epidemiology\/oxfordasp."},{"key":"720_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105\u201314.","journal-title":"Contemp Clin Trials"},{"key":"720_CR11","unstructured":"Review Manager (RevMan) [Computer program]. The Cochrane Collaboration, 2020."},{"issue":"43","key":"720_CR12","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","volume":"41","author":"E Freisinger","year":"2020","unstructured":"Freisinger E, Ger\u00df J, Makowski L, Marschall U, Reinecke H, Baumgartner H, Koeppe J, Diller GP. Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients. Eur Heart J. 2020;41(43):4168\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa844. (PMID: 33184662).","journal-title":"Eur Heart J"},{"issue":"327","key":"720_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijcard.2020.11.024","volume":"15","author":"N Kawamatsu","year":"2021","unstructured":"Kawamatsu N, Ishizu T, Machino-Ohtsuka T, Masuda K, Horigome H, Takechi F, Tateno S, Fukuda T, Kijima Y, Shiina Y, Komiyama N, Niwa K, Hiramatsu Y, Ieda M. Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: a multicenter retrospective cohort study. Int J Cardiol. 2021;15(327):74\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.024. (Epub 2020 Nov 19 PMID: 33220361).","journal-title":"Int J Cardiol"},{"issue":"3","key":"720_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10557-021-07298-5","volume":"37","author":"A Kazerouninia","year":"2023","unstructured":"Kazerouninia A, Georgekutty J, Kendsersky P, Byrne RD, Seto B, Chu PY, Wang Y, Rodriguez FH 3rd, Smith C, Saraf A, Lloyd MS, Frischhertz BP, Parekh DR, Ermis PR, Franklin WJ, Lam WW. A multisite retrospective review of direct oral anticoagulants compared to warfarin in adult Fontan patients. Cardiovasc Drugs Ther. 2023;37(3):519\u201327. https:\/\/doi.org\/10.1007\/s10557-021-07298-5. (Epub 2022 Jan 13. PMID: 35022950; PMCID: PMC11040449).","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"720_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011474","volume":"8","author":"AC Egbe","year":"2019","unstructured":"Egbe AC, Miranda WR, Ammash NM, Missula VR, Jadav R, Najam M, Kothapalli S, Connolly HM. Outcomes of anticoagulation therapy in adults with tetralogy of fallot. J Am Heart Assoc. 2019;8(5): e011474. https:\/\/doi.org\/10.1161\/JAHA.118.011474. (PMID:30803288;PMCID:PMC6474918).","journal-title":"J Am Heart Assoc"},{"issue":"12_Supplement","key":"720_CR16","doi-asserted-by":"publisher","first-page":"A325","DOI":"10.1016\/S0735-1097(14)60325-9","volume":"63","author":"M Ezekowitz","year":"2014","unstructured":"Ezekowitz M, Parise H, Nagarakanti R, et al. comparison of dabigatran versus warfarin in patients with atrial fibrillation and valvular heart disease: the Re-ly\u00ae trial. J Am Coll Cardiol. 2014;63(12_Supplement):A325. https:\/\/doi.org\/10.1016\/S0735-1097(14)60325-9.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"720_CR17","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, \u0160pinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093\u2013104. https:\/\/doi.org\/10.1056\/NEJMoa1310907. (Epub 2013 Nov 19 PMID: 24251359).","journal-title":"N Engl J Med"},{"issue":"5","key":"720_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s00392-021-01957-1","volume":"111","author":"MV Huisman","year":"2022","unstructured":"Huisman MV, Teutsch C, Lu S, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Lohmann R, Gurusamy VK, Bartels DB, Lip GYH, GLORIA-AF Investigators. Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry. Clin Res Cardiol. 2022;111(5):548\u201359. https:\/\/doi.org\/10.1007\/s00392-021-01957-1. (Epub 2022 Mar 16. PMID: 35294623; PMCID: PMC9054866).","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"720_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1107039. (Epub 2011 Aug 27 PMID: 21870978).","journal-title":"N Engl J Med"},{"issue":"299","key":"720_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","volume":"15","author":"H Yang","year":"2020","unstructured":"Yang H, Bouma BJ, Dimopoulos K, Khairy P, Ladouceur M, Niwa K, Greutmann M, Schwerzmann M, Egbe A, Scognamiglio G, Budts W, Veldtman G, Opotowsky AR, Broberg CS, Gumbiene L, Meijboom FJ, Rutz T, Post MC, Moe T, Lipczy\u0144ska M, Tsai SF, Chakrabarti S, Tobler D, Davidson W, Morissens M, van Dijk A, Buber J, Bouchardy J, Skoglund K, Christersson C, Kronvall T, Konings TC, Alonso-Gonzalez R, Mizuno A, Webb G, Laukyte M, Sieswerda GTJ, Shafer K, Aboulhosn J, Mulder BJM. Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. Int J Cardiol. 2020;15(299):123\u201330. https:\/\/doi.org\/10.1016\/j.ijcard.2019.06.014. (Epub 2019 Jun 13 PMID: 31307847).","journal-title":"Int J Cardiol"},{"issue":"3","key":"720_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.amjcard.2015.10.062","volume":"117","author":"C Pujol","year":"2016","unstructured":"Pujol C, Niesert AC, Engelhardt A, Schoen P, Kusmenkov E, Pittrow D, Ewert P, Kaemmerer H. Usefulness of direct oral anticoagulants in adult congenital heart disease. Am J Cardiol. 2016;117(3):450\u20135. https:\/\/doi.org\/10.1016\/j.amjcard.2015.10.062. (Epub 2015 Nov 18 PMID: 26725103).","journal-title":"Am J Cardiol"},{"issue":"4","key":"720_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/chd.12603","volume":"13","author":"J Georgekutty","year":"2018","unstructured":"Georgekutty J, Kazerouninia A, Wang Y, Ermis PR, Parekh DR, Franklin WJ, Lam WW. Novel oral anticoagulant use in adult Fontan patients: a single center experience. Congenit Heart Dis. 2018;13(4):541\u20137. https:\/\/doi.org\/10.1111\/chd.12603. (Epub 2018 Mar 24 PMID: 29575675).","journal-title":"Congenit Heart Dis"},{"issue":"6","key":"720_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10557-022-07357-5","volume":"37","author":"PG Br\u00e1s","year":"2023","unstructured":"Br\u00e1s PG, Mano TB, Rito T, Castelo A, Ferreira V, Agapito A, Ferreira RC, Pinto F, de Sousa L. Non-VKA oral anticoagulants in adult congenital heart disease: a single-center study. Cardiovasc Drugs Ther. 2023;37(6):1077\u201386. https:\/\/doi.org\/10.1007\/s10557-022-07357-5. (Epub 2022 Jun 17 PMID: 35713747).","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"720_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000985","volume":"6","author":"H Yang","year":"2019","unstructured":"Yang H, Veldtman GR, Bouma BJ, Budts W, Niwa K, Meijboom F, Scognamiglio G, Egbe AC, Schwerzmann M, Broberg C, Morissens M, Buber J, Tsai S, Polyzois I, Post MC, Greutmann M, Van Dijk A, Mulder BJ, Aboulhosn J. Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe. Open Heart. 2019;6(1): e000985. https:\/\/doi.org\/10.1136\/openhrt-2018-000985. (PMID:31245011;PMCID:PMC6560660).","journal-title":"Open Heart."},{"issue":"406","key":"720_CR25","doi-asserted-by":"publisher","first-page":"131993","DOI":"10.1016\/j.ijcard.2024.131993","volume":"1","author":"A Kartas","year":"2024","unstructured":"Kartas A, Papazoglou AS, Moysidis DV, Despotopoulos S, Baroutidou A, Kosmidis D, Koutsakis A, Liori S, Apostolopoulou S, Frogoudaki A, Tzifa A, Galatas A, Alexandridis G, Spiridonidis E, Doundoulakis I, Karagiannidis E, Karvounis H, Ziakas A, Giannakoulas G. Use of apixaban in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study. Int J Cardiol. 2024;1(406):131993. https:\/\/doi.org\/10.1016\/j.ijcard.2024.131993. (Epub 2024 Mar 31. PMID: 38565389).","journal-title":"Int J Cardiol"},{"issue":"24","key":"720_CR26","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.jacc.2023.10.010","volume":"82","author":"RM Payne","year":"2023","unstructured":"Payne RM, Burns KM, Glatz AC, et al. Apixaban for the prevention of thromboembolism in pediatric heart disease. J Am Coll Cardiol. 2023;82(24):2296\u2013309.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"720_CR27","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","volume":"80","author":"MA Portman","year":"2022","unstructured":"Portman MA, Jacobs JP, Newburger JW, et al. Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease. J Am Coll Cardiol. 2022;80(24):2301\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"720_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacc.2022.10.037","volume":"81","author":"J Van den Eynde","year":"2023","unstructured":"Van den Eynde J, Possner M, Alahdab F, Veldtman G, Goldstein BH, Rathod RH, Hoskoppal AK, Saraf A, Feingold B, Alsaied T. Thromboprophylaxis in patients with Fontan circulation. J Am Coll Cardiol. 2023;81(4):374\u201389. https:\/\/doi.org\/10.1016\/j.jacc.2022.10.037. (PMID:36697138;PMCID:PMC11040452).","journal-title":"J Am Coll Cardiol"},{"key":"720_CR29","doi-asserted-by":"publisher","unstructured":"Al Yousef S. Efficacy and safety of direct-acting oral anticoagulants (DOAC) versus vitamin K antagonist (VKA) for patients with congenital heart disease (CHD). Cardiol Young. 2023 Apr;33:S63. https:\/\/doi.org\/10.1017\/S1047951123001099. [Conference abstract, 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology, 2023 Apr 26-29, Dublin, Ireland]","DOI":"10.1017\/S1047951123001099"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-025-00720-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00720-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T07:08:04Z","timestamp":1751699284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-025-00720-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s40256-025-00720-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"19 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by SCELC, Statewide California Electronic Library Consortium.No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"A.S., J.K., F.I., E.W., G.M., K.D., and K.M. declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"A.S., G.M., K.D., and K.M. contributed to the study conception and design. Material preparation, data collection, and analysis were performed by A.S., J.K., F.I., and E.W. The first draft of the manuscript was written by A.S. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"All data generated or analyzed during this study are included in this published article (and its Supplementary Materials).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}